Physician profile
Diane E Rosen
NPI 1740490879
$2,078.76
in general payments reported to CMS, 2019-2025
28 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $87.89 · 2021: $112 · 2022: $322 · 2023: $340 · 2024: $474 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.60 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $345.42 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $216.18 | 2019-2025 | |
| Abbvie INC. | $215.78 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $210.02 | 2019-2025 | Third Wave, Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $110.40 | 2021-2023 | Paragard T 380a |
| Organon LLC | $108.31 | 2023-2025 | Nexplanon |
| Pfizer INC. | $90.42 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $89.38 | 2023-2025 | |
| Meditrina | $68.30 | 2022 | |
| Channel Medsystems, INC. | $66.16 | 2022 | |
| Merck Sharp & Dohme LLC | $59.97 | 2019 | |
| Sumitomo Pharma America, INC. | $56.85 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $53.37 | 2024-2025 | Zurzuvae |
| Amgen INC. | $51.21 | 2025 | Evenity |
| Therapeuticsmd, INC. | $43.47 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $31.71 | 2019 | |
| Exeltis, USA INC. | $31.31 | 2023-2025 | Slynd |
| Lsi Solutions INC | $30.24 | 2024 | Fornisee |
| Lupin INC. | $28.50 | 2019-2021 | |
| Duchesnay USA Incorporated | $26.53 | 2019 | |
| Daiichi Sankyo INC. | $24.41 | 2021 | |
| Kci USA, INC. | $22.60 | 2020 | |
| Allergan, INC. | $19.66 | 2019 | |
| Monaghan Medical Corporation | $18.19 | 2023 | Aerobika |
| Aspira Women'S Health INC | $17.94 | 2021 | |
| Evofem Biosciences, INC. | $15.73 | 2022 | |
| Aesculap, INC. | $14.92 | 2019 | |
| Myovant Sciences INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.